Optellum is delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the biggest ever randomized clinical study, to learn more about Optellum and our work to redefine early interception of lung cancer with AI.
US National Lung Screening Trial PI visits Optellum
- Post author:Vaclav Potesil
- Post published:March 18, 2018
- Post category:News and PR